Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - paracetamol; codeine phosphate hemihydrate; caffeine - effervescent tablet - 500 mg/8 mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - paracetamol; codeine phosphate hemihydrate; doxylamine succinate; caffeine - film-coated tablet - 450mg/10mg/5mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - ibuprofen; codeine phosphate hemihydrate - film-coated tablet - 200/12.8 milligram(s) - opioids in combination with non-opioid analgesics; codeine and ibuprofen - nsaid - for the relief of pain in such conditions as: rheumatic and muscular pain, backache, migraine, dental pain, dysmenorrhoea, feverishness, symptoms of cold and flu.

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - paracetamol; codeine phosphate hemihydrate - film-coated tablet - 500 mg/12.8 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

redpharm drug, inc. - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] have not provided adequate analgesia, or are not expected to provide adequate analgesia have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated in patients with: patients with significant respiratory depression [see warnings]. patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings]. postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy [see warni

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

par pharmaceutical, inc. - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - codeine phosphate 30 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia, have not provided adequate analgesia, or are not expected to provide adequate analgesia, - have not been tolerated, or are not expected to be tolerated. have not been tolerated, or are not expected to be tolerated. acetaminophen and codeine phosphate tablets are contraindicated for: • all children younger than 12 years of age [see warnings ]. • post-operative management in children younger than 18 years of age following tonsillectomy and/or aden

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - codeine phosphate hemihydrate,paracetamol -

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: stearic acid; maize starch; pregelatinised maize starch; povidone; magnesium stearate; purified talc; croscarmellose sodium; potassium sorbate; microcrystalline cellulose - prodeine forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 8 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: soluble maize starch; povidone; microcrystalline cellulose; stearic acid; potassium sorbate; magnesium stearate; maize starch; purified talc - for the relief of acute moderate pain

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - codeine phosphate hemihydrate, quantity: 12.8 mg; ibuprofen, quantity: 200 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; pregelatinised maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - for the temporary relief of acute moderate pain and inflammation